Search results
Roche Holding AG ADR
WKN: 891106 / Symbol: RHHBY / Name: Roche / Stock / Pharmaceuticals / Large Cap /

Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer
Roche RHHBY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Itovebi (inavolisib)

Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer
Roche RHHBY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Itovebi (inavolisib)

Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer
Roche RHHBY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Itovebi (inavolisib)

Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer
Roche RHHBY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Itovebi (inavolisib)

Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer
Roche RHHBY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Itovebi (inavolisib)

Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer
Roche RHHBY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Itovebi (inavolisib)

Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer
Roche RHHBY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Itovebi (inavolisib)

Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer
Roche RHHBY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Itovebi (inavolisib)

Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer
Roche RHHBY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Itovebi (inavolisib)

Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer
Roche RHHBY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Itovebi (inavolisib)

Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer
Roche RHHBY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Itovebi (inavolisib)

Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer
Roche RHHBY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Itovebi (inavolisib)

Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer
Roche RHHBY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Itovebi (inavolisib)

Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer
Roche RHHBY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Itovebi (inavolisib)

Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer
Roche RHHBY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Itovebi (inavolisib)

Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer
Roche RHHBY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Itovebi (inavolisib)